Organisation paid for research Program year 2025 Source: CMS Open Payments

Walgreens Store 19361

Neither a doctor nor a teaching hospital

Research payments

$26,595

82 payments

Through program year 2025, Walgreens Store 19361 is reported as receiving $26,595 in research payments, across 82 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$5,433	78
2024	Research	$21,162	4

Breakdown

Who paid Research payments · program years 2024–2025

Boehringer Ingelheim International GmbH $14,119 73 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $12,476 9 payments

Studies the money was for Research payments · program years 2024–2025

phase III efficacy for obesity - with T2DM $17,770 2 payments
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus $5,371 77 payments
Phase III efficacy for obesity - without T2DM $3,392 2 payments
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity without type 2 diabetes $62 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.